Data on this page show the responses of Aboriginal and Torres Strait Islander people (or their parent/carer) who received an influenza vaccine and completed an AusVaxSafety survey sent in the days following vaccination.

The influenza vaccines currently in use for Aboriginal and Torres Strait Islander people include:

Standard influenza vaccines

  • Afluria® Quad (individuals aged 5 years and older)
  • Fluarix Tetra® (individuals aged 6 months and older)
  • Flucelvax® Quad (individuals aged 6 months and older)
  • FluQuadri® (individuals aged 6 months and older)
  • Influvac® Tetra (individuals aged 6 months and older)
  • Vaxigrip Tetra® (individuals aged 6 months and older).

Adjuvanted or high-dose vaccines

  • Fluad® Quad (individuals aged 65 years and over)
  • Fluzone® High-Dose Quad (individuals aged 60 years and over).

These data provide a profile of what to expect in the days following your influenza vaccination and can assist in planning for vaccination.

Data on this page will be updated weekly throughout the 2024 influenza season.
 

AusVaxSafety's active vaccine safety surveillance system complements the enhanced safety surveillance activities of the Therapeutic Goods Administration.

Further information on the influenza vaccines can be found at the links below:

Last updated April 2024